Status:

COMPLETED

Intradetrusor Botulinum Toxin A for OAB Via 1 Versus 10 Injections: A Randomized Clinical Trial

Lead Sponsor:

University of California, Irvine

Collaborating Sponsors:

Kaiser Permanente

St. Joseph Hospital of Orange

Conditions:

Overactive Bladder

Urinary Urge Incontinence

Eligibility:

FEMALE

18+ years

Phase:

PHASE4

Brief Summary

Patients with either overactive bladder (OAB) or urgency urinary incontinence (UUI) with be randomized (like a flip of a coin) to receive 100 units of bladder Botox® at either one injection site or te...

Detailed Description

Intradetrusor (bladder) Botulinum toxin A (BTA or Botox®) is a well-established treatment for urinary urgency incontinence (UUI).\[1,2\] While this treatment's efficacy in comparison to alternative th...

Eligibility Criteria

Inclusion

  • Female
  • 18 years old or greater
  • Diagnosis of overactive bladder (urinary urgency or frequency, OAB) or urinary urgency incontinence (UUI)

Exclusion

  • Have a diagnosis of neurogenic bladder
  • Received intravesical botox injections within prior 6 months
  • Current treatment with either: SNM, PTNS, or OAB medications - need wash out as below
  • SNM - turn device off for at least 2 weeks prior to procedure, off during 3-month follow up window
  • PTNS - no treatments within 2 weeks of start, none during 3-month post-procedure follow up window
  • OAB meds - 2 week wash out period prior to injection, none during 3-month post-procedure follow up window
  • Currently pregnant or trying to get pregnant
  • Contraindications to Botox® - hypersensitivity to Botox®, inability to self-catheterize/refusal to have indwelling catheter
  • Have a UTI (can enroll after treatment)
  • Have urinary retention (PVR\>150cc on two occasions)
  • Do not speak English or Spanish

Key Trial Info

Start Date :

May 1 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 31 2024

Estimated Enrollment :

116 Patients enrolled

Trial Details

Trial ID

NCT05308979

Start Date

May 1 2022

End Date

March 31 2024

Last Update

February 28 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of California Irvine Medical Center

Orange, California, United States, 92868

Intradetrusor Botulinum Toxin A for OAB Via 1 Versus 10 Injections: A Randomized Clinical Trial | DecenTrialz